APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuropeptide Y Receptor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neuropeptide Y Receptor Industry Growth and Trends Forecast to 2032

5 July 2026101 pages

Choose your research edition.

Industry ResearchNeuropeptide Y Receptor Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuropeptide Y Receptor Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Neuropeptide Y Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuropeptide Y Receptor Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuropeptide Y Receptor Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Neuropeptide Y Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neuropeptide Y Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neuropeptide Y Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neuropeptide Y Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neuropeptide Y Receptor include Gila Therapeutics, Novo Nordisk, XL-protein, Lilly Eli, Novartis, Pfizer, Merck & Co, Mannkind and Gilead Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neuropeptide Y Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neuropeptide Y Receptor market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neuropeptide Y Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neuropeptide Y Receptor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neuropeptide Y Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neuropeptide Y Receptor Market by Company

Gila Therapeutics

Novo Nordisk

XL-protein

Lilly Eli

Novartis

Pfizer

Merck & Co

Mannkind

Gilead Sciences

Genentech

Neuropeptide Y Receptor Segment by Type

Food Grade

Pharmaceutical Grade

Neuropeptide Y Receptor Segment by Application

Medicine

Food Additives

Others

Neuropeptide Y Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuropeptide Y Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuropeptide Y Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuropeptide Y Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neuropeptide Y Receptor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neuropeptide Y Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Food Grade Table 2. Major Company of Pharmaceutical Grade Table 3. Global Neuropeptide Y Receptor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Neuropeptide Y Receptor Sales by Type (2021-2026) & (t) Table 5. Global Neuropeptide Y Receptor Sales Market Share in Volume by Type (2021-2026) Table 6. Global Neuropeptide Y Receptor Sales by Type (2021-2026) & (US$ Million) Table 7. Global Neuropeptide Y Receptor Sales Market Share in Value by Type (2021-2026) Table 8. Global Neuropeptide Y Receptor Price by Type (2021-2026) & (USD/t) Table 9. Global Neuropeptide Y Receptor Sales by Type (2027-2032) & (t) Table 10. Global Neuropeptide Y Receptor Sales Market Share in Volume by Type (2027-2032) Table 11. Global Neuropeptide Y Receptor Sales by Type (2027-2032) & (US$ Million) Table 12. Global Neuropeptide Y Receptor Sales Market Share in Value by Type (2027-2032) Table 13. Global Neuropeptide Y Receptor Price by Type (2027-2032) & (USD/t) Table 14. North America Neuropeptide Y Receptor Sales by Type (2021-2026) & (t) Table 15. North America Neuropeptide Y Receptor Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Neuropeptide Y Receptor Sales by Type (2021-2026) & (t) Table 17. Europe Neuropeptide Y Receptor Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Neuropeptide Y Receptor Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Neuropeptide Y Receptor Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Neuropeptide Y Receptor Sales by Type (2021-2026) & (t) Table 21. Latin America Neuropeptide Y Receptor Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Neuropeptide Y Receptor Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Neuropeptide Y Receptor Sales by Type (2021-2026) & (US$ Million) Table 24. Neuropeptide Y Receptor Industry Trends Table 25. Neuropeptide Y Receptor Industry Drivers Table 26. Neuropeptide Y Receptor Industry Opportunities and Challenges Table 27. Neuropeptide Y Receptor Industry Restraints Table 28. Global Neuropeptide Y Receptor Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Neuropeptide Y Receptor Revenue Market Share by Company (2021-2026) Table 30. Global Neuropeptide Y Receptor Sales by Company (2021-2026) & (t) Table 31. Global Neuropeptide Y Receptor Sales Share by Company (2021-2026) Table 32. Global Neuropeptide Y Receptor Market Price by Company (2021-2026) & (USD/t) Table 33. Global Neuropeptide Y Receptor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Neuropeptide Y Receptor Major Company Production Sites and Headquarters Table 35. Global Neuropeptide Y Receptor Company, Product Type & Application Table 36. Global Neuropeptide Y Receptor Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Neuropeptide Y Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Neuropeptide Y Receptor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Neuropeptide Y Receptor Sales by Region (2021-2026) & (t) Table 41. Global Neuropeptide Y Receptor Sales Market Share in Volume by Region (2021-2026) Table 42. Global Neuropeptide Y Receptor Sales by Region (2021-2026) & (US$ Million) Table 43. Global Neuropeptide Y Receptor Sales Market Share in Value by Region (2021-2026) Table 44. Global Neuropeptide Y Receptor Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Global Neuropeptide Y Receptor Sales by Region (2027-2032) & (t) Table 46. Global Neuropeptide Y Receptor Sales Market Share in Volume by Region (2027-2032) Table 47. Global Neuropeptide Y Receptor Sales by Region (2027-2032) & (US$ Million) Table 48. Global Neuropeptide Y Receptor Sales Market Share in Value by Region (2027-2032) Table 49. Global Neuropeptide Y Receptor Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 50. Global Neuropeptide Y Receptor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Neuropeptide Y Receptor Sales by Application (2021-2026) & (t) Table 52. Global Neuropeptide Y Receptor Sales Market Share in Volume by Application (2021-2026) Table 53. Global Neuropeptide Y Receptor Sales by Application (2021-2026) & (US$ Million) Table 54. Global Neuropeptide Y Receptor Sales Market Share in Value by Application (2021-2026) Table 55. Global Neuropeptide Y Receptor Price by Application (2021-2026) & (USD/t) Table 56. Global Neuropeptide Y Receptor Sales by Application (2027-2032) & (t) Table 57. Global Neuropeptide Y Receptor Sales Market Share in Volume by Application (2027-2032) Table 58. Global Neuropeptide Y Receptor Sales by Application (2027-2032) & (US$ Million) Table 59. Global Neuropeptide Y Receptor Sales Market Share in Value by Application (2027-2032) Table 60. Global Neuropeptide Y Receptor Price by Application (2027-2032) & (USD/t) Table 61. North America Neuropeptide Y Receptor Sales by Application (2021-2026) & (t) Table 62. North America Neuropeptide Y Receptor Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Neuropeptide Y Receptor Sales by Application (2021-2026) & (t) Table 64. Europe Neuropeptide Y Receptor Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Neuropeptide Y Receptor Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Neuropeptide Y Receptor Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Neuropeptide Y Receptor Sales by Application (2021-2026) & (t) Table 68. Latin America Neuropeptide Y Receptor Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Neuropeptide Y Receptor Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Neuropeptide Y Receptor Sales by Application (2021-2026) & (US$ Million) Table 71. Gila Therapeutics Company Information Table 72. Gila Therapeutics Business Overview Table 73. Gila Therapeutics Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Gila Therapeutics Neuropeptide Y Receptor Product Portfolio Table 75. Gila Therapeutics Recent Development Table 76. Novo Nordisk Company Information Table 77. Novo Nordisk Business Overview Table 78. Novo Nordisk Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Novo Nordisk Neuropeptide Y Receptor Product Portfolio Table 80. Novo Nordisk Recent Development Table 81. XL-protein Company Information Table 82. XL-protein Business Overview Table 83. XL-protein Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. XL-protein Neuropeptide Y Receptor Product Portfolio Table 85. XL-protein Recent Development Table 86. Lilly Eli Company Information Table 87. Lilly Eli Business Overview Table 88. Lilly Eli Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Lilly Eli Neuropeptide Y Receptor Product Portfolio Table 90. Lilly Eli Recent Development Table 91. Novartis Company Information Table 92. Novartis Business Overview Table 93. Novartis Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Novartis Neuropeptide Y Receptor Product Portfolio Table 95. Novartis Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Pfizer Neuropeptide Y Receptor Product Portfolio Table 100. Pfizer Recent Development Table 101. Merck & Co Company Information Table 102. Merck & Co Business Overview Table 103. Merck & Co Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Merck & Co Neuropeptide Y Receptor Product Portfolio Table 105. Merck & Co Recent Development Table 106. Mannkind Company Information Table 107. Mannkind Business Overview Table 108. Mannkind Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Mannkind Neuropeptide Y Receptor Product Portfolio Table 110. Mannkind Recent Development Table 111. Gilead Sciences Company Information Table 112. Gilead Sciences Business Overview Table 113. Gilead Sciences Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. Gilead Sciences Neuropeptide Y Receptor Product Portfolio Table 115. Gilead Sciences Recent Development Table 116. Genentech Company Information Table 117. Genentech Business Overview Table 118. Genentech Neuropeptide Y Receptor Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Genentech Neuropeptide Y Receptor Product Portfolio Table 120. Genentech Recent Development Table 121. North America Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 122. North America Neuropeptide Y Receptor Sales by Country (2021-2026) & (t) Table 123. North America Neuropeptide Y Receptor Sales Market Share by Country (2021-2026) Table 124. North America Neuropeptide Y Receptor Sales Forecast by Country (2027-2032) & (t) Table 125. North America Neuropeptide Y Receptor Sales Market Share Forecast by Country (2027-2032) Table 126. North America Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Neuropeptide Y Receptor Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Neuropeptide Y Receptor Market Share by Country (2021-2026) Table 129. North America Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Neuropeptide Y Receptor Market Share Forecast by Country (2027-2032) Table 131. Europe Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 132. Europe Neuropeptide Y Receptor Sales by Country (2021-2026) & (t) Table 133. Europe Neuropeptide Y Receptor Sales Market Share by Country (2021-2026) Table 134. Europe Neuropeptide Y Receptor Sales Forecast by Country (2027-2032) & (t) Table 135. Europe Neuropeptide Y Receptor Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Neuropeptide Y Receptor Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Neuropeptide Y Receptor Market Share by Country (2021-2026) Table 139. Europe Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Neuropeptide Y Receptor Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Neuropeptide Y Receptor Sales by Country (2021-2026) & (t) Table 143. Asia-Pacific Neuropeptide Y Receptor Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Neuropeptide Y Receptor Sales Forecast by Country (2027-2032) & (t) Table 145. Asia-Pacific Neuropeptide Y Receptor Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Neuropeptide Y Receptor Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Neuropeptide Y Receptor Market Share by Country (2021-2026) Table 149. Asia-Pacific Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Neuropeptide Y Receptor Market Share Forecast by Country (2027-2032) Table 151. Latin America Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 152. Latin America Neuropeptide Y Receptor Sales by Country (2021-2026) & (t) Table 153. Latin America Neuropeptide Y Receptor Sales Market Share by Country (2021-2026) Table 154. Latin America Neuropeptide Y Receptor Sales Forecast by Country (2027-2032) & (t) Table 155. Latin America Neuropeptide Y Receptor Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Neuropeptide Y Receptor Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Neuropeptide Y Receptor Market Share by Country (2021-2026) Table 159. Latin America Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Neuropeptide Y Receptor Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Neuropeptide Y Receptor Sales by Country (2021-2026) & (t) Table 163. Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Neuropeptide Y Receptor Sales Forecast by Country (2027-2032) & (t) Table 165. Middle East and Africa Neuropeptide Y Receptor Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Neuropeptide Y Receptor Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Neuropeptide Y Receptor Market Share by Country (2021-2026) Table 169. Middle East and Africa Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Neuropeptide Y Receptor Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Neuropeptide Y Receptor Distributors List Table 174. Neuropeptide Y Receptor Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Neuropeptide Y Receptor Image Figure 2. Global Neuropeptide Y Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuropeptide Y Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuropeptide Y Receptor Sales (2021-2032) & (t) Figure 5. Food Grade Image Figure 6. Global Food Grade Sales YoY Growth (2021-2032) & (t) Figure 7. Pharmaceutical Grade Image Figure 8. Global Pharmaceutical Grade Sales YoY Growth (2021-2032) & (t) Figure 9. Global Neuropeptide Y Receptor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Neuropeptide Y Receptor Market Share by Type 2025 VS 2032 Figure 11. North America Neuropeptide Y Receptor Sales Market Share in Volume by Type in 2025 Figure 12. North America Neuropeptide Y Receptor Sales Market Share in Value by Type in 2025 Figure 13. Europe Neuropeptide Y Receptor Sales Market Share in Volume by Type in 2025 Figure 14. Europe Neuropeptide Y Receptor Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Neuropeptide Y Receptor Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Neuropeptide Y Receptor Sales Market Share in Value by Type in 2025 Figure 17. Latin America Neuropeptide Y Receptor Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Neuropeptide Y Receptor Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Neuropeptide Y Receptor Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Neuropeptide Y Receptor Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Neuropeptide Y Receptor Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medicine Image Figure 24. Global Medicine Sales YoY Growth (2021-2032) & (t) Figure 25. Food Additives Image Figure 26. Global Food Additives Sales YoY Growth (2021-2032) & (t) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (t) Figure 29. Global Neuropeptide Y Receptor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Neuropeptide Y Receptor Market Share by Application 2025 VS 2032 Figure 31. North America Neuropeptide Y Receptor Sales Market Share in Volume by Application in 2025 Figure 32. North America Neuropeptide Y Receptor Sales Market Share in Value by Application in 2025 Figure 33. Europe Neuropeptide Y Receptor Sales Market Share in Volume by Application in 2025 Figure 34. Europe Neuropeptide Y Receptor Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Neuropeptide Y Receptor Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Neuropeptide Y Receptor Sales Market Share in Value by Application in 2025 Figure 37. Latin America Neuropeptide Y Receptor Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Neuropeptide Y Receptor Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Neuropeptide Y Receptor Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Neuropeptide Y Receptor Sales Market Share in Value by Application in 2025 Figure 41. North America Neuropeptide Y Receptor Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 42. North America Neuropeptide Y Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Neuropeptide Y Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Neuropeptide Y Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Neuropeptide Y Receptor Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. Europe Neuropeptide Y Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Neuropeptide Y Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Neuropeptide Y Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Neuropeptide Y Receptor Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Asia-Pacific Neuropeptide Y Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Neuropeptide Y Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Neuropeptide Y Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Neuropeptide Y Receptor Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Latin America Neuropeptide Y Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Neuropeptide Y Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Neuropeptide Y Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Neuropeptide Y Receptor Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Middle East and Africa Neuropeptide Y Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Neuropeptide Y Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Neuropeptide Y Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Neuropeptide Y Receptor Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Neuropeptide Y Receptor Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade
  • Pharmaceutical Grade
Applications
  • Medicine
  • Food Additives
  • Others
Companies covered
  • Gila Therapeutics
  • Novo Nordisk
  • XL-protein
  • Lilly Eli
  • Novartis
  • Pfizer
  • Merck & Co
  • Mannkind
  • Gilead Sciences
  • Genentech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neuropeptide Y Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neuropeptide Y Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neuropeptide Y Receptor Market by Type
  6. 1.3.1 Food Grade
  7. 1.3.2 Pharmaceutical Grade
  8. 1.4 Global Neuropeptide Y Receptor Market Size by Type
  9. 1.4.1 Global Neuropeptide Y Receptor Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Neuropeptide Y Receptor Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Neuropeptide Y Receptor Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Neuropeptide Y Receptor Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Neuropeptide Y Receptor Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Neuropeptide Y Receptor Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Neuropeptide Y Receptor Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Neuropeptide Y Receptor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neuropeptide Y Receptor Industry Trends
  2. 2.2 Neuropeptide Y Receptor Industry Drivers
  3. 2.3 Neuropeptide Y Receptor Industry Opportunities and Challenges
  4. 2.4 Neuropeptide Y Receptor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neuropeptide Y Receptor Revenue (2021-2026)
  2. 3.2 Global Top Players by Neuropeptide Y Receptor Sales (2021-2026)
  3. 3.3 Global Top Players by Neuropeptide Y Receptor Price (2021-2026)
  4. 3.4 Global Neuropeptide Y Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neuropeptide Y Receptor Major Company Production Sites & Headquarters
  6. 3.6 Global Neuropeptide Y Receptor Company, Product Type & Application
  7. 3.7 Global Neuropeptide Y Receptor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neuropeptide Y Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neuropeptide Y Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neuropeptide Y Receptor Tier 1, Tier 2, and Tier 3
4 Neuropeptide Y Receptor Regional Status and Outlook
  1. 4.1 Global Neuropeptide Y Receptor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neuropeptide Y Receptor Historic Market Size by Region
  3. 4.2.1 Global Neuropeptide Y Receptor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neuropeptide Y Receptor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neuropeptide Y Receptor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neuropeptide Y Receptor Forecasted Market Size by Region
  7. 4.3.1 Global Neuropeptide Y Receptor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neuropeptide Y Receptor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neuropeptide Y Receptor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neuropeptide Y Receptor by Application
  1. 5.1 Neuropeptide Y Receptor Market by Application
  2. 5.1.1 Medicine
  3. 5.1.2 Food Additives
  4. 5.1.3 Others
  5. 5.2 Global Neuropeptide Y Receptor Market Size by Application
  6. 5.2.1 Global Neuropeptide Y Receptor Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Neuropeptide Y Receptor Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Neuropeptide Y Receptor Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Neuropeptide Y Receptor Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Neuropeptide Y Receptor Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Neuropeptide Y Receptor Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Neuropeptide Y Receptor Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Neuropeptide Y Receptor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Gila Therapeutics
  2. 6.1.1 Gila Therapeutics Company Information
  3. 6.1.2 Gila Therapeutics Business Overview
  4. 6.1.3 Gila Therapeutics Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Gila Therapeutics Neuropeptide Y Receptor Product Portfolio
  6. 6.1.5 Gila Therapeutics Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Neuropeptide Y Receptor Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 XL-protein
  14. 6.3.1 XL-protein Company Information
  15. 6.3.2 XL-protein Business Overview
  16. 6.3.3 XL-protein Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 XL-protein Neuropeptide Y Receptor Product Portfolio
  18. 6.3.5 XL-protein Recent Developments
  19. 6.4 Lilly Eli
  20. 6.4.1 Lilly Eli Company Information
  21. 6.4.2 Lilly Eli Business Overview
  22. 6.4.3 Lilly Eli Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lilly Eli Neuropeptide Y Receptor Product Portfolio
  24. 6.4.5 Lilly Eli Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Neuropeptide Y Receptor Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Neuropeptide Y Receptor Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Merck & Co
  38. 6.7.1 Merck & Co Company Information
  39. 6.7.2 Merck & Co Business Overview
  40. 6.7.3 Merck & Co Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck & Co Neuropeptide Y Receptor Product Portfolio
  42. 6.7.5 Merck & Co Recent Developments
  43. 6.8 Mannkind
  44. 6.8.1 Mannkind Company Information
  45. 6.8.2 Mannkind Business Overview
  46. 6.8.3 Mannkind Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mannkind Neuropeptide Y Receptor Product Portfolio
  48. 6.8.5 Mannkind Recent Developments
  49. 6.9 Gilead Sciences
  50. 6.9.1 Gilead Sciences Company Information
  51. 6.9.2 Gilead Sciences Business Overview
  52. 6.9.3 Gilead Sciences Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Gilead Sciences Neuropeptide Y Receptor Product Portfolio
  54. 6.9.5 Gilead Sciences Recent Developments
  55. 6.10 Genentech
  56. 6.10.1 Genentech Company Information
  57. 6.10.2 Genentech Business Overview
  58. 6.10.3 Genentech Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Genentech Neuropeptide Y Receptor Product Portfolio
  60. 6.10.5 Genentech Recent Developments
7 North America by Country
  1. 7.1 North America Neuropeptide Y Receptor Sales by Country
  2. 7.1.1 North America Neuropeptide Y Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neuropeptide Y Receptor Sales by Country (2021-2026)
  4. 7.1.3 North America Neuropeptide Y Receptor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neuropeptide Y Receptor Market Size by Country
  6. 7.2.1 North America Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neuropeptide Y Receptor Market Size by Country (2021-2026)
  8. 7.2.3 North America Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neuropeptide Y Receptor Sales by Country
  2. 8.1.1 Europe Neuropeptide Y Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neuropeptide Y Receptor Sales by Country (2021-2026)
  4. 8.1.3 Europe Neuropeptide Y Receptor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neuropeptide Y Receptor Market Size by Country
  6. 8.2.1 Europe Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neuropeptide Y Receptor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neuropeptide Y Receptor Sales by Country
  2. 9.1.1 Asia-Pacific Neuropeptide Y Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neuropeptide Y Receptor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neuropeptide Y Receptor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neuropeptide Y Receptor Market Size by Country
  6. 9.2.1 Asia-Pacific Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neuropeptide Y Receptor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neuropeptide Y Receptor Sales by Country
  2. 10.1.1 South America Neuropeptide Y Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neuropeptide Y Receptor Sales by Country (2021-2026)
  4. 10.1.3 South America Neuropeptide Y Receptor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neuropeptide Y Receptor Market Size by Country
  6. 10.2.1 South America Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neuropeptide Y Receptor Market Size by Country (2021-2026)
  8. 10.2.3 South America Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neuropeptide Y Receptor Sales by Country
  2. 11.1.1 Middle East and Africa Neuropeptide Y Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neuropeptide Y Receptor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neuropeptide Y Receptor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neuropeptide Y Receptor Market Size by Country
  6. 11.2.1 Middle East and Africa Neuropeptide Y Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neuropeptide Y Receptor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neuropeptide Y Receptor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neuropeptide Y Receptor Value Chain Analysis
  2. 12.1.1 Neuropeptide Y Receptor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neuropeptide Y Receptor Production Mode & Process
  7. 12.2 Neuropeptide Y Receptor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neuropeptide Y Receptor Distributors
  10. 12.2.3 Neuropeptide Y Receptor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst